The role of adiponectin and cytokines in Amyotrophic lateral sclerosis: assessment of disease progression and survival status
Jing Zhang, Mei Tian, Tongyang Niu, Rui Li, Qi Liu, Man Liu, Xiaomeng Zhou, Hui Dong, Yaling Liu · 2026
Read The role of adiponectin and cytokines in Amyotrophic lateral sclerosis: assessment of disease progression and survival status by Jing Zhang, Mei Tian, Tongyang Niu, Rui Li, Qi Liu, Man Liu, Xiaomeng Zhou, Hui Dong, Yaling Liu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13439534.txt.
Description
Jing Zhang's team tracked adiponectin and cytokines in 2026 among eighty ALS patients over eighteen months to predict progression and survival. ALS kills through respiratory failure within a few years, yet markers that flag fast progressors are scarce. Blood adiponectin, IL-10, progression rate, and function scores were tested in survival models with hazard ratios.
Fast progressors showed lower adiponectin and IL-10, and all four markers, adiponectin, IL-10, progression rate, and function score, predicted survival risk in the models. Clinicians get candidate blood and clinical markers for stratifying ALS care and trials. The small, single-cohort design means the markers need independent validation before bedside use.
Catalog record
| CREATOR | Jing Zhang, Mei Tian, Tongyang Niu, Rui Li, Qi Liu, Man Liu, Xiaomeng Zhou, Hui Dong, Yaling Liu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |